News Releases

2024

• DoD's medical advanced development activity Change of Command rescheduled for October 28 (18-Oct)
• Army Announces FDA Clearance of Whole Blood Rapid Test to Help with Assessment of Traumatic Brain Injury (1-Apr)

2023

• Study seeks new treatments for post-traumatic stress disorder in veterans, military personnel (27-Oct)
• Ultrasound Field Portable (USFP) solicitation released – qualifying industry developers invited to apply (1-Aug)
• USAMMDA, Johns Hopkins Applied Physics Lab to host Industry Day Aug. 28 (1-Aug)

2022

• Traumatic Brain Injury Biomarkers Point to Recovery (11-Aug)

2021

• Army Announces FDA Clearance of Field-Deployable TBI Blood Test (11-Jan)
• Army Announces FDA Marketing Approval for Next Generation Diagnostics System Global Fever Panel (8-Jan)

2020

• USAMRDC Announces FDA Licensure for Severe Malaria Treatment (27-May)
• PNSY Partners with USAMMDA on 3-D Printed Test Swabs (19-May)
• USAMMDA Announces Agreement with Gilead Sciences to Provide Investigational New Drug for Warfighters Exposed to Coronavirus Disease (10-Mar)

2019

• US Army Awarded Contract for Joint Deployable Computerized Scanner (26-Jun)
• US Army Announces Award to Validate TBI Point-of-care Device (30-Apr)

2018

• U.S. Army Partners with TRACK-TBI Network to Rapidly Advance TBI Drug Development (12-Oct)
• DOD Awards Agreement to Test Drugs to Treat PTSD (4-Oct)
• Breakthrough in Malaria Prevention
  USAMMDA Announces FDA Approval of New Antimalarial Drug (10-Aug)
• DOD-sponsored trial of HBO₂ for TBI results announced (9-May)
• DOD Finds Success with First Blood-test for Traumatic Brain Injury (14-Feb)
• Priority Review Designation Received for Tafenoquine (13-Feb)

2017

• US Army Signs New Technology Licensing Partner for the SHRAIL™ (15-Dec)

2016

• USAMMDA and Funded Partnering Organizations Release First Publication in Series Detailing Potential TBI Clinical Endpoints (31-Oct)
• Advanced Tissue Biofabrication Manufacturing Innovation - Funding Opportunity Announcement (16-Jun)

2013

• Phase III Data Show Easy-to-Use Antibiotic Cream Has High Cure Rate, Few Side Effects in Treatment of Neglected Disease (7-Jan)

2012

• Neurotrauma and Psychological Health Project Management Office Signs Interagency Agreement with the Veterans Affairs Cooperative Studies Program (2-Jul)
• Malaria, Dengue, And Leishmania Rapid Detection Devises To Be Fielded In Medical Equipment Sets (8-Jun)

2011

• U.S. Army Medical Research and Materiel Command Showcases Tunisian Collaboration to Develop a New Treatment for Cutaneous Leishmaniasis (23-Nov)
• USAMRMC Protects Soldiers Against Unseen Enemy (18-Oct)
• FDA Approves the SMART Leish PCR assay for Diagnosing Leishmania in Individuals with Signs and Symptoms of Leishmaniasis (27-May)
• Tunisian Officials Visit USAMRMC (27-May)
• FDA Approves the New Adenovirus Vaccine (16-Mar)

2010

• U.S. Army Medical Materiel Development Activity Partners with French Military to Develop a new Treatment for Cutaneous Leishmaniasis (19-Feb)